NASDAQ : MTVA
MetaVia Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.12 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 7.38M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 7.20M | 6.91M | 7.26M | 6.73M | 8.64M | 8.75M |
| Research & Development | 7.73M | 6.80M | 21.55M | 9.16M | 2.78M | 6.55M |
| Operating Expenses | 14.93M | 13.71M | 28.81M | 15.89M | 11.42M | 15.30M |
| Operating Income | -14.93M | -13.71M | -28.81M | -15.89M | -11.42M | -15.30M |
| Interest Expense | -2.19M | |||||
| Interest & Investment Income | 394.00K | 510.00K | 920.00K | 461.00K | 14.00K | |
| Currency Exchange Gain (Loss) | -8.00K | |||||
| Other Non Operating Income (Expenses) | 91.00K | 225.00K | 297.00K | 2.96M | 7.93M | |
| EBT Excluding Unusual Items | -14.45M | -12.97M | -27.59M | -12.47M | -5.68M | -15.28M |
| Gain (Loss) on Sale of Assets | -75.00K | |||||
| Pretax Income | -14.45M | -12.97M | -27.59M | -12.47M | -13.97M | -15.28M |
| Net Income | -14.45M | -12.97M | -27.59M | -12.47M | -13.97M | -15.28M |
| Net Income to Common | -14.45M | -12.97M | -27.59M | -12.47M | -13.97M | -15.28M |
| Shares Outstanding (Basic) | 3.88M | 1.77M | 705.19K | 461.01K | 29.25K | |
| Shares Outstanding (Diluted) | 3.88M | 1.77M | 705.19K | 461.01K | 29.25K | |
| EPS (Basic) | -3.72 | -7.35 | -39.13 | -27.05 | -477.57 | |
| EPS (Diluted) | -3.72 | -7.35 | -39.13 | -27.06 | -477.62 | |
| Free Cash Flow | -15.84M | -15.70M | -24.72M | -10.85M | -11.71M | -15.14M |
| Free Cash Flow Per Share | -4.08 | -8.89 | -35.05 | -23.53 | -400.46 | |
| EBITDA | -14.91M | -13.69M | -28.79M | -15.88M | -11.40M | -15.25M |
| D&A For EBITDA | 19.00K | 19.00K | 20.00K | 6.00K | 20.00K | 48.00K |
| EBIT | -14.93M | -13.71M | -28.81M | -15.89M | -11.42M | -15.30M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 12.63M | 10.28M | 16.02M | 22.43M | 33.36M | 16.39M |
| Short-Term Investments | 2.00K | 32.00K | 16.00K | 39.00K | ||
| Cash & Short-Term Investments | 12.64M | 10.31M | 16.03M | 22.47M | 33.36M | 16.39M |
| Prepaid Expenses | 345.00K | 54.00K | 39.00K | 38.00K | 197.00K | |
| Other Current Assets | 86.00K | 511.00K | 168.00K | |||
| Total Current Assets | 13.07M | 10.88M | 16.07M | 22.51M | 33.53M | 16.58M |
| Property, Plant & Equipment | 183.00K | 227.00K | 167.00K | 248.00K | 2.00K | 215.00K |
| Other Long-Term Assets | 21.00K | 21.00K | 21.00K | 21.00K | ||
| Total Assets | 13.27M | 11.12M | 16.26M | 22.78M | 33.53M | 16.80M |
| Accounts Payable | 921.00K | 1.06M | 3.88M | 821.00K | 708.00K | 830.00K |
| Accrued Expenses | 5.30M | 4.24M | 3.90M | 4.25M | 280.00K | 1.30M |
| Current Portion of Leases | 74.00K | 68.00K | 78.00K | 67.00K | 26.00K | |
| Other Current Liabilities | 46.00K | 285.00K | 416.00K | 824.00K | 10.80M | |
| Total Current Liabilities | 6.35M | 5.65M | 8.27M | 5.96M | 11.78M | 2.16M |
| Long-Term Leases | 103.00K | 142.00K | 58.00K | 136.00K | 45.00K | |
| Total Liabilities | 6.45M | 5.79M | 8.33M | 6.10M | 11.78M | 2.20M |
| Common Stock | 7.00K | 2.00K | 1.00K | 5.00K | 25.00K | 1.00K |
| Additional Paid-In Capital | 164.78M | 154.16M | 143.79M | 124.94M | 117.52M | 96.42M |
| Retained Earnings | -157.97M | -148.83M | -135.86M | -108.27M | -95.80M | -81.83M |
| Comprehensive Income & Other | 4.00K | |||||
| Total Common Equity | 6.82M | 5.33M | 7.93M | 16.68M | 21.75M | 14.60M |
| Shareholders' Equity | 6.82M | 5.33M | 7.93M | 16.68M | 21.75M | 14.60M |
| Total Liabilities & Equity | 13.27M | 11.12M | 16.26M | 22.78M | 33.53M | 16.80M |
| Total Debt | 177.00K | 210.00K | 136.00K | 203.00K | 71.00K | |
| Net Cash (Debt) | 12.46M | 10.10M | 15.90M | 22.27M | 33.36M | 16.32M |
| Net Cash Per Share | 3.21 | 5.72 | 22.54 | 48.31 | 1,140.81 | |
| Filing Date Shares Outstanding | 6.59M | 5.09M | 786.81K | 446.00K | 308.83K | 10.10K |
| Total Common Shares Outstanding | 6.58M | 2.31M | 785.18K | 446.00K | 289.05K | 10.10K |
| Working Capital | 6.72M | 5.23M | 7.80M | 16.55M | 21.75M | 14.43M |
| Book Value Per Share | 1.04 | 2.31 | 10.10 | 37.41 | 75.25 | 1,445.39 |
| Tangible Book Value | 6.82M | 5.33M | 7.93M | 16.68M | 21.75M | 14.60M |
| Tangible Book Value Per Share | 1.04 | 2.31 | 10.10 | 37.41 | 75.25 | 1,445.39 |
| Machinery | 90.00K | 90.00K | 88.00K | 80.00K | 30.00K | 221.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -14.45M | -12.97M | -27.59M | -12.47M | -13.97M | -15.28M |
| Depreciation & Amortization | 19.00K | 19.00K | 20.00K | 6.00K | 20.00K | 48.00K |
| Other Amortization | 2.19M | |||||
| Loss (Gain) From Sale of Assets | 75.00K | |||||
| Asset Writedown & Restructuring Costs | 8.21M | |||||
| Stock-Based Compensation | 398.00K | 411.00K | 538.00K | 222.00K | 854.00K | 662.00K |
| Other Operating Activities | 53.00K | -228.00K | -293.00K | -2.95M | -7.93M | 24.00K |
| Change in Accounts Payable | -1.73M | -2.82M | 3.06M | 113.00K | -202.00K | -1.16M |
| Change in Other Net Operating Assets | -127.00K | -111.00K | -441.00K | 4.28M | -966.00K | 578.00K |
| Operating Cash Flow | -15.84M | -15.70M | -24.71M | -10.80M | -11.71M | -15.13M |
| Capital Expenditures | -2.00K | -8.00K | -50.00K | -3.00K | ||
| Sale of Property, Plant & Equipment | 8.00K | |||||
| Cash Acquisitions | -583.00K | |||||
| Investing Cash Flow | -2.00K | -8.00K | -50.00K | 8.00K | -586.00K | |
| Issuance of Common Stock | 13.86M | 11.21M | 20.00M | 32.25M | 24.11M | |
| Repurchase of Common Stock | -12.00K | -48.00K | ||||
| Other Financing Activities | -2.98M | -1.24M | -1.65M | -80.00K | -3.57M | -2.09M |
| Financing Cash Flow | 10.88M | 9.96M | 18.30M | -80.00K | 28.68M | 22.03M |
| Foreign Exchange Rate Adjustments | -8.00K | |||||
| Net Cash Flow | -4.96M | -5.74M | -6.42M | -10.93M | 16.98M | 6.30M |
| Free Cash Flow | -15.84M | -15.70M | -24.72M | -10.85M | -11.71M | -15.14M |
| Free Cash Flow Per Share | -4.08 | -8.89 | -35.05 | -23.53 | -400.46 | |
| Levered Free Cash Flow | -11.09M | -11.28M | -15.16M | -15.51M | 4.24M | -10.00M |
| Unlevered Free Cash Flow | -11.09M | -11.28M | -15.16M | -15.51M | 5.61M | -10.00M |
| Change in Working Capital | -1.86M | -2.93M | 2.62M | 4.40M | -1.17M | -584.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 7.71M | 18.54M | 17.49M | 17.93M | 13.61M | 32.44M |
| Enterprise Value | -4.75M | 4.33M | -4.04M | -7.68M | 7.26M | 25.54M |
| Last Close Price | 1.12 | 8.42 | 22.33 | 40.66 | 63.14 | 3,220.80 |
| PB Ratio | 1.08 | 3.48 | 2.21 | 1.07 | 0.63 | 2.22 |
| P/TBV Ratio | 1.08 | 3.48 | 2.21 | 1.07 | 0.63 | 2.22 |
| Debt / Equity Ratio | 0.03 | 0.04 | 0.02 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -1.83 | -1.89 | -2.00 | -1.33 | -1.53 | -1.12 |
| Net Debt / EBITDA Ratio | 0.84 | 0.74 | 0.55 | 1.40 | 2.93 | 1.07 |
| Net Debt / FCF Ratio | 0.79 | 0.64 | 0.64 | 2.05 | 2.85 | 1.08 |
| Quick Ratio | 1.99 | 1.82 | 1.94 | 3.77 | 2.83 | 7.60 |
| Current Ratio | 2.06 | 1.93 | 1.94 | 3.78 | 2.85 | 7.69 |
| Return on Equity (ROE) | -175.68% | -195.61% | -224.18% | -64.89% | -76.85% | -140.22% |
| Return on Assets (ROA) | -58.82% | -62.58% | -92.24% | -35.26% | -28.36% | -68.87% |
| Return on Capital Employed (ROCE) | -215.60% | -250.40% | -360.60% | -94.40% | -52.50% | -104.50% |
| Earnings Yield | -318.05% | -69.99% | -157.75% | -69.53% | -102.60% | -47.11% |
| FCF Yield | -214.60% | -84.72% | -141.32% | -60.49% | -86.04% | -46.66% |
| Buyback Yield / Dilution | -270.81% | -150.43% | -52.97% | -1,476.32% |